BB, great post, and thanks for sharing your valuable information with the board.
It's all about connecting the dots. Taken from
my post 1658.
"The question, can CYRX meet the demand? Do we have one, the capabilities to meet any large CRO's requirements, and two, if we don't, what are we doing to satisfy that need?"
BB, you just answered my questions for me.
One, Lake Forest in your opinion isn't equipped to handle any large orders, and two,
how will that problem be solved, in your opinion, out-source, which will require additional capital.
Your post would indicate two things to me. One, 3rd quarter MAY NOT be as promising, and two, until CYRX is able to secure additional capital to expand production, perhaps we shouldn't expect a large signing until than.
I'll say this much, if CYRX pulls off additional financing in this credit crisis, and it's not Roswell, that should send a very strong signal to all investors that this company has something really special, or is very close to something significant, IMO.
GLTA
It's all about connecting the dots. Taken from
my post 1658.
"The question, can CYRX meet the demand? Do we have one, the capabilities to meet any large CRO's requirements, and two, if we don't, what are we doing to satisfy that need?"
BB, you just answered my questions for me.
One, Lake Forest in your opinion isn't equipped to handle any large orders, and two,
how will that problem be solved, in your opinion, out-source, which will require additional capital.
Your post would indicate two things to me. One, 3rd quarter MAY NOT be as promising, and two, until CYRX is able to secure additional capital to expand production, perhaps we shouldn't expect a large signing until than.
I'll say this much, if CYRX pulls off additional financing in this credit crisis, and it's not Roswell, that should send a very strong signal to all investors that this company has something really special, or is very close to something significant, IMO.
GLTA
Recent CYRX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 06:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:30:40 PM
- Cryoport Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 12:00:17 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 08:32:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:31:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 08:30:45 PM
- Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026 • PR Newswire (US) • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 10:32:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:01:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:46 PM
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/03/2026 09:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series • PR Newswire (US) • 02/11/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2026 09:56:32 PM
